Choosing the Best Surgery for Young Women with Breast Cancer
Part of Cancer, Skin clinical trials.
This study looks at how to make the best surgical choices for young women with breast cancer. It compares different surgery options to help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 44 years old.
- You have been newly diagnosed with breast cancer that is stage 0, 1, 2, or 3 and has not spread to other parts of the body.
- You speak English or Spanish.
- Your cancer is not stage 4 and has not come back after previous treatment.
- You have cancer in only one breast.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
This trial is testing a decision aid to help women newly diagnosed with breast cancer choose between different surgery options. It looks at how well this tool supports you in making a choice that fits your values and preferences.
This study is testing a new tool to help women with early-stage breast cancer decide between lumpectomy (removing just the tumor) or mastectomy (removing the entire breast). The tool is designed for women who have not yet talked to a surgeon about their options.
This study compares two different surgical approaches for removing early-stage breast cancer while preserving the breast. You may qualify if you have a single, small tumor and want to keep your breast.
This study tests a decision-making tool to help people with newly diagnosed breast cancer make choices about removing the other (opposite) breast as a preventive step. It may help you think through risks and options in a clearer, more structured way.
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
Hear when a new Breast Cancer Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.